ACXP (ACXP) Stock Price & Analysis
ACXP (ACXP) rose 1.43% to USD 1.42 as of September 8, 2026 at 07:37 UTC, according to Nexqual real-time market data.
ACXP last closed at USD 1.42; the session ranged USD 1.39–1.42 on volume of 47,678 shares. Market capitalization is —, with a 52-week range of USD 1.31–8.34 (NCM). Source: Nexqual, September 8, 2026 at 07:37 UTC.
Key Statistics (as of September 8, 2026 at 07:37 UTC)
| Price | USD 1.42 |
|---|---|
| Change | ▲ 1.43% (up) |
| Previous Close | USD 1.42 |
| Open | USD 1.42 |
| Day Range | USD 1.39 – 1.42 |
| 52-Week Range | USD 1.31 – 8.34 |
| Volume | 47,678 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (ACXP)
Nexqual's technical model rates ACXP "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 07:37 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 46.13 (neutral) |
| vs SMA50 | Below (USD 1.49) |
| MACD | -0.02 (negative) |
From ACXP's Latest SEC 10-K Filing (filed 2026-03-12)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BBLG | Bone Biologics Corp | USD 0.57 | ▲ 3.27% |
| ABOS | Acumen Pharmaceuticals, Inc. | USD 3.18 | ▲ 2.58% |
| RNAZ | TransCode Therapeutics, Inc. | USD 2.06 | ▲ 2.49% |
| ABVC | ABVC Biopharma, Inc. | USD 0.96 | ▲ 10.98% |
| INAB | IN8bio, Inc. | USD 1.2 | ▲ 9.09% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 07:37 UTC. This page is informational and not investment advice.